Skip to main content

Table 3 Outcomes for LELC types and treatment modalities

From: Lymphoepithelioma-like, a variant of urothelial carcinoma of the urinary bladder: a case report and systematic review for optimal treatment modality for disease-free survival

LELC Type

Cases

NED

p-value

DOD

p-value

 Pure

62

71.0%

0.00002

1.6%

0.0001

 Predominant

36

75.0%

0.00002

5.6%

0.002

 Mixed

38

31.6%

-

28.9%

-

Treatment

Cases

NED

p-value

DOD

p-value

 MM

112

67.9%

0.002

7.1%

0.04

 RC+

59

67.8%

0.002

10.2%

0.08

 PC+

8

50.0%

0.21

12.5%

0.22

 TURBT+

45

71.1%

0.002

2.2%

0.012

 TURBT−

21

33.3%

-

23.8%

-

  1. p-values calculated against mixed type and against TURBT-only
  2. NED no evidence of disease, DOD died of disease, MM multi-modality overall treatments including RC+, PC+, and TURBT+; RC+, radical cystectomy + adjuvant therapy, PC+ partial cystectomy + adjuvant therapy, TURBT+ transurethral resection of the bladder + adjuvant therapy, TURBT- transurethral resection of the bladder only